mortality data from the basket late trial and premier registry
DESCRIPTION
Mortality Data From the BASKET LATE Trial and PREMIER Registry. BASKET LATE Trial: Cardiac Death in DES vs. BMS (%) p=0.09. PREMIER Registry Data: All Cause Death According to Minimum 30 day thienopyridine Therapy Duration (%) pTRANSCRIPT
www. Clinical trial results.org
Mortality Data From the BASKET LATE Trial Mortality Data From the BASKET LATE Trial and PREMIER Registryand PREMIER Registry
Mortality Data From the BASKET LATE Trial Mortality Data From the BASKET LATE Trial and PREMIER Registryand PREMIER Registry
• In the BASKET LATE Trial, cardiac death trended higher in the DES group than in the In the BASKET LATE Trial, cardiac death trended higher in the DES group than in the BMS group during the year following clopidogrel discontinuation (1.2% vs. 0%, p=0.09).BMS group during the year following clopidogrel discontinuation (1.2% vs. 0%, p=0.09).
• Data from the PREMIER registry looked exclusively at AMI patients who received DES and Data from the PREMIER registry looked exclusively at AMI patients who received DES and suggested that patients who discontinued thienopyridine therapy early - within 30 days in suggested that patients who discontinued thienopyridine therapy early - within 30 days in this instance - were significantly more likely to die over the next 11 months (p<0.0001).this instance - were significantly more likely to die over the next 11 months (p<0.0001).
1.2
0.00
1
2
DES BMS
1.2
0.00
1
2
DES BMS
BASKET LATE Trial: Cardiac Death in DES vs. BMS (%)
p=0.09
7.5
0.7
0
2
4
6
8
Stoppedthienopyridines
Stayed onthienopyridines
7.5
0.7
0
2
4
6
8
Stoppedthienopyridines
Stayed onthienopyridines
PREMIER Registry Data: All Cause Death According to Minimum 30 day thienopyridine Therapy Duration (%)
p<0.0001
% p
atie
nts
% p
atie
nts
% p
atie
nts
% p
atie
nts